Meta-Analysis
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. May 24, 2025; 16(5): 102611
Published online May 24, 2025. doi: 10.5306/wjco.v16.i5.102611
Relationship between skeletal muscle mass and prognosis in patients with liver cancer receiving targeted therapy: A meta-analysis
Ling-Hong Wan, Bi-Jing Mao, Bin Wang
Ling-Hong Wan, Department of Gastroenterology, Daping Hospital, Army Medical University, Third Military Medical University, Chongqing 400042, China
Bi-Jing Mao, Department of Oncology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing 401120, China
Bin Wang, Department of Oncology, The Seventh People’s Hospital of Chongqing, Affiliated Central Hospital of Chongqing University of Technology, Chongqing 400054, China
Co-corresponding authors: Bi-Jing Mao and Bin Wang.
Author contributions: Wan LH, Mao BJ, and Wang B edited and reviewed the manuscript, and approved the final article; Mao BJ and Wang B contributed equally as co-corresponding authors.
Supported by Chongqing Young and Middle-aged Medical High-end Talents, No. YXGD202405; Chongqing District and County Head Goose Talents, Chongqing Science and Technology and Health Joint Scientific Research Project on Traditional Chinese Medicine, No. 2024ZYYB036; and Chongqing Banan District Science and Technology and Health Joint Scientific Research Project on Traditional Chinese Medicine, No. BNWJ202300112.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Bin Wang, Department of Oncology, The Seventh People’s Hospital of Chongqing, Affiliated Central Hospital of Chongqing University of Technology, No. 1 Lijiatuo Industry Federation Village, Banan District, Chongqing 400054, China. wangjianlinbin@163.com
Received: October 24, 2024
Revised: February 1, 2025
Accepted: April 1, 2025
Published online: May 24, 2025
Processing time: 207 Days and 20 Hours
Core Tip

Core Tip: In recent years, many studies have found that sarcopenia is related to the survival of patients with liver cancer, which may lead to worse prognosis. However, some studies have demonstrated that the presence or absence of sarcopenia has no significant effect on the prognosis of patients with liver cancer. Therefore, this study intends to evaluate the value of sarcopenia in evaluating the prognosis of patients with liver cancer receiving targeted therapy through meta-analysis, so as to guide the nutritional support therapy for the patients in clinical practice.